SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.89+1.2%Jan 14 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (6474)6/5/2002 1:18:48 PM
From: David Howe  Read Replies (1) of 52153
 
Thanks Peter.

<< My view is that MLNM is cheap at these prices, particularly if you take a multi-year view. >>

It's been painful, but I've adopted the the "multi-year view" for most of my portfolio at this point. <g> MLNM looks like it has great potential. Who knows, maybe they and other biotechs will hit their prime in a few years just as the market achieves bull market status once again. If that happens, please remind me to take some profits. <g>

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News